D. E. Shaw & Co., Inc. - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q2 2021$559,000
+126.3%
55,587
+122.3%
0.00%–
Q1 2021$247,000–25,000–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q3 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders